(342 days)
Not Found
None
No
The provided text does not contain any keywords or descriptions related to AI or ML technology.
Yes
The device is intended for "percutaneous isolation and aspiration of fresh thrombus from vessels in the vascular system" and "removal of thromboemboli from native or synthetic vessels within the arterial circulation," which are therapeutic interventions.
No
The device's intended use is for percutaneous isolation and aspiration of fresh thrombus, temporary occlusion of blood vessels, isolated infusion of fluids, blood sampling, and removal of thromboemboli. These are all therapeutic or interventional actions, not diagnostic ones. There is no mention of the device being used to identify or characterize a disease or condition.
No
The intended use and device description (even though not found in the provided text, the intended use strongly implies a physical catheter system) describe a device for percutaneous isolation and aspiration of thrombus, which is a hardware-based procedure involving a catheter. There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes a device that is used in vivo (within the body) for procedures like percutaneous isolation and aspiration of thrombus, temporary occlusion of blood vessels, isolated infusion of fluids, and blood sampling. These are all procedures performed directly on the patient's vascular system.
- Lack of IVD Characteristics: An IVD device is used to examine specimens (like blood, urine, or tissue) outside of the body to provide information about a person's health. The description of this device's function does not involve the analysis of biological specimens in vitro.
Therefore, the ANGIODYNAMICS, Inc. DCAT System and Cohn Thrombectomy Catheter are medical devices used for therapeutic and diagnostic procedures performed directly on the patient, not for in vitro diagnostic testing.
N/A
Intended Use / Indications for Use
The ANGIODYNAMICS, Inc. DCAT System is for the percutaneous isolation and aspiration of fresh thrombus from vessels in the vascular system. Additionally, it may also be used for temporary occlusion of blood vessels, isolated infusion of fluids, and blood sampling.
The ANGIODYNAMICS, Inc. Cohn Thrombectomy Catheter is intended to be used for temporary occlusion and removal of thromboemboli from native or synthetic vessels within the arterial circulation.
Product codes
DXE
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vessels in the vascular system, native or synthetic vessels within the arterial circulation
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5150 Embolectomy catheter.
(a)
Identification. An embolectomy catheter is a balloon-tipped catheter that is used to remove thromboemboli, i.e., blood clots which have migrated in blood vessels from one site in the vascular tree to another.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of three human profiles facing to the right. The profiles are stacked on top of each other, with the top profile being the largest and the bottom profile being the smallest. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the image.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 17 1998
Mr. Brian Kunst Vice President, Regulatory Affairs and Quality Assurance AngioDynamics, Inc. 603 Queensbury Avenue Queensbury, NY 12804
K971314 Re: Trade Names: Dialysis-Crossed Aspiration Thrombectomy (DCAT) Catheter System and Cohn Thrombectomy Catheter II (two) Regulatory Class: Product Code: DXE Dated: December 15, 1997 Received: December 17, 1997
Dear Mr. Kunst:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the qeneral controls provisions of the Act. The general controls provisions of the Act include requirements for
annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this Page 2 - Mr. Brian Kunst
1
response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Page 1 of 1
510(k) Number (if known): K971314
Device Name: ANGIODYNAMICS, Inc. DCAT Thrombectomy Catheter System
Indications For Use:
The ANGIODYNAMICS, Inc. DCAT System is for the percutaneous isolation and aspiration of fresh thrombus from vessels in the vascular system. Additionally, it may also be used for temporary occlusion of blood vessels, isolated infusion of fluids, and blood sampling.
Device Name: ANGIODYNAMICS, Inc. Cohn Thrombectomy Catheter
Indications For Use:
The ANGIODYNAMICS, Inc. Cohn Thrombectomy Catheter is intended to be used for temporary occlusion and removal of thromboemboli from native or synthetic vessels within the arterial circulation.
(Division Sign-Off)
Division of Cardiovascular, Respiratory,
and Neurological Devices
510(k) Number K971314
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF -------------------------------------------------------------------------------------------------------------NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
or
Over-The-Counter Use
(Optional Format 1-2-96)
0000000